由Informa Pharmaceutical Science出版（原名Ashley Publications）。國(guó)際標(biāo)準(zhǔn)書號(hào)：1465-6566。《藥物治療專家意見》（EOP）于2001年每月出版（12期），是同行評(píng)審藥物評(píng)估和評(píng)審的獨(dú)特來(lái)源。藥物治療專家意見致力于對(duì)新批準(zhǔn)的藥物和藥物類別進(jìn)行系統(tǒng)評(píng)估和審查。藥物治療專家意見旨在全面覆蓋新批準(zhǔn)化合物的新文獻(xiàn)和經(jīng)驗(yàn)，并評(píng)估這些新藥物對(duì)特定疾病現(xiàn)有藥物治療的可能影響。藥物治療專家意見集中在過(guò)去2-5年中藥典可獲得的新藥和藥物類別上，分析它們對(duì)治療指南的實(shí)際或推定影響。藥物治療專家意見采用系統(tǒng)化的覆蓋方法，每個(gè)問(wèn)題都集中在一個(gè)主要的治療領(lǐng)域。

Published by Informa Pharmaceutical Science (formerly Ashley Publications). ISSN: 1465-6566.Expert Opinion on Pharmacotherapy (EOP) is published monthly (12 issues) in 2001, and is a unique source of peer-reviewed Drug Evaluations and Reviews. Expert Opinion on Pharmacotherapy is dedicated to the systematic evaluation and review of newly approved drugs and drug classes. Expert Opinion on Pharmacotherapy aims to provide comprehensive coverage of the emerging literature on and experience with newly approved compounds and an evaluated assessment of the likely impact of these new agents on existing pharmacotherapy of specific diseases. Expert Opinion on Pharmacotherapy focuses on new drugs and drug classes that have become available to the pharmacopoeia in the past 2 - 5 years, analysing their actual or presumptive effect on treatment guidelines. Expert Opinion on Pharmacotherapy adopts a systematic approach to coverage, with each issue focusing on one of the major therapeutic areas.